S
SABS//CIK 0001833214
SAB Biotherapeutics, Inc.
Market Data
$3.54−$0.32 (−8.29%)
SABS · Last trade
Prev Close
$3.86
Range (29d)
$3.54 – $4.00
Recent Filings
- 8-K273.2 KBSAB Biotherapeutics, Inc.Jul 7, 8:15 AM ET·0001193125-26-296936
- 8-K209.1 KBSAB Biotherapeutics, Inc.Jun 18, 4:35 PM ET·0001193125-26-275976
- 10-Q14.6 MBSAB Biotherapeutics, Inc.May 12, 7:35 AM ET·0001193125-26-218195
- 8-K567.3 KBSAB Biotherapeutics, Inc.May 4, 4:35 PM ET·0001193125-26-204125
- 8-K6.0 MBSAB Biotherapeutics, Inc.Apr 22, 8:13 AM ET·0001193125-26-168569
- 8-K1.1 MBSAB Biotherapeutics, Inc.Mar 18, 8:28 PM ET·0001193125-26-114730
- 8-K15.3 MBSAB Biotherapeutics, Inc.Mar 10, 7:35 AM ET·0001193125-26-099376
- 10-K23.2 MBSAB Biotherapeutics, Inc.Mar 9, 5:10 PM ET·0001833214-26-000003
- 8-K14.1 MBSAB Biotherapeutics, Inc.Jan 12, 4:47 PM ET·0001193125-26-010515
- 8-K268.6 KBSAB Biotherapeutics, Inc.Jan 7, 8:30 AM ET·0001193125-26-005487
Insiders
10- Bausch Christoph LawrenceCHIEF OPERATING OFFICER
- Beyer Russell PChief Financial Officer
- Big Cypress Holdings LLCDirector, CEO and CFO, 10% Owner
- Carillo Carlos NSVP Regulatory Affairs
- Collins Stephen D.Director
- Conley Mark WilliamSee Remarks
- Ellias Helen K.Director
- Erickson Bruce KippChief Operating Officer
- Finnegan FrederickChief Business Officer
- Giberson ScottDirector
Tickers
Addresses
business
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
mailing
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
Former Names
- Big Cypress Acquisition Corp.2021-10-22